Dec 11, 2025 · Library of Congress
Introduced in Senate
S. 3452
119th CongressIn committeeBiological Intellectual Property Protection Act of 2025
Biological Intellectual Property Protection Act of 2025
Sponsored by Tom Cotton (Republican-AR)
Cosponsors
3
Actions
2
Roll calls
0
Amendments
0
Related bills
1
Actions
Dec 11, 2025 · Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Latest activity
Activity
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20
Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1071S. 1096S. 1387S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Fdd Action · Jul 20
Fdd Action reported 2nd Quarter (Apr 1 - June 30) lobbying for Fdd Action — $240,000
BillsH.Con.Res. 38H.Con.Res. 40H.Con.Res. 75H.Con.Res. 84H.Con.Res. 86H.J.Res. 176H.J.Res. 200H.R. 36H.R. 425H.R. 881H.R. 1048H.R. 1422H.R. 1736H.R. 1800H.R. 2158H.R. 2212H.R. 2505H.R. 2658H.R. 2683H.R. 3307H.R. 3447H.R. 3563H.R. 4397H.R. 4505H.R. 4531H.R. 4920H.R. 4930H.R. 5490H.R. 5853H.R. 6058H.R. 6106H.R. 6230H.R. 6322H.R. 6331H.R. 6469H.R. 6624H.R. 6875H.R. 6988H.R. 6996H.R. 7003H.R. 7037H.R. 7126H.R. 7146H.R. 7178H.R. 7184H.R. 7273H.R. 7380H.R. 7540H.R. 7552H.R. 7567H.R. 7622H.R. 7625H.R. 7668H.R. 7924H.R. 8019H.R. 8022H.R. 8036H.R. 8069H.R. 8106H.R. 8168H.R. 8169H.R. 8170H.R. 8177H.R. 8202H.R. 8283H.R. 8284H.R. 8433H.R. 8516H.R. 8558H.R. 8559H.R. 8595H.R. 8649H.R. 8665H.R. 8693H.R. 8700H.R. 8718H.R. 8730H.R. 8787H.R. 8800H.R. 8901H.R. 9020H.R. 9087H.R. 9102H.R. 9129H.R. 9147H.R. 9227H.R. 9232H.R. 9256H.R. 9322H.R. 9366H.R. 9450H.R. 9451H.R. 9495H.R. 9550H.R. 9592H.Res. 564H.Res. 1246H.Res. 1379S. 63S. 556S. 933S. 1296S. 1473S. 1705S. 1744S. 1889S. 1962S. 2132S. 2293S. 2677S. 2904S. 3050S. 3172S. 3181S. 3249S. 3360S. 3404S. 3452S. 3496S. 3519S. 3855S. 3900S. 4192S. 4219S. 4281S. 4296S. 4379S. 4380S. 4392S. 4423S. 4424S. 4429S. 4443S. 4446S. 4456S. 4525S. 4544S. 4565S. 4570S. 4600S. 4665S. 4711S. 4723S. 4784S. 4826S. 4835S. 4853S.J.Res. 114S.J.Res. 123S.J.Res. 163S.J.Res. 184S.J.Res. 185S.Res. 236
Lobbying reported · Glaxosmithkline · Jul 16
Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1071S. 1096S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
You’re all caught up.